Breakout Stock to Watch: Pharma Stock Breaks Out of Rounding Bottom Pattern

The broader market has remained volatile in recent sessions, but stock-specific opportunities continue to emerge as several companies show strong price action and improving technical structures. One such stock is Zydus Lifesciences (ZYDUSLIFE), which has witnessed a strong breakout on the daily chart, supported by higher volume and improving momentum.

Breakout Stock to Watch for Swing Trading: Zydus Lifesciences (ZYDUSLIFE)

Zydus Lifesciences is a pharmaceutical company engaged in the development, manufacturing and marketing of a wide range of healthcare products. Its business portfolio includes generic medicines, active pharmaceutical ingredients, vaccines, biosimilars and specialty healthcare products, serving both domestic and international markets.

The stock has attracted buying interest after maintaining a broader uptrend from its April lows. Following a rally towards the Rs 1,220 zone in September, the stock underwent a corrective phase and gradually formed a rounded base near the Rs 1,100–1,150 levels. The recent recovery towards its previous high has set the stage for a fresh technical breakout.

Technical Setup: Stock Breaks Out of Rounding Bottom Pattern

From a technical perspective, Zydus Lifesciences has formed a rounding bottom pattern on the daily chart. The stock initially faced resistance near the Rs 1,220 zone before entering a corrective phase during October. It gradually formed a rounded base near the Rs 1,100–1,150 levels and subsequently recovered towards its previous resistance, indicating improving buying interest.

The stock has now broken above the Rs 1,215–1,220 resistance zone with a strong bullish candle and closed at Rs 1,245.50, gaining 5.16%. Volume stood at approximately 3.66 million shares, indicating increased participation during the breakout. A sustained move above this resistance zone could confirm the completion of the rounding bottom formation and support further upside.

Momentum Indicators Turn Positive

The technical setup remains supportive across multiple time frames. Zydus Lifesciences is trading above its key 20, 50, 100 and 200 EMAs, with the 20 EMA around Rs 1,174.32, 50 EMA near Rs 1,158.18, 100 EMA at Rs 1,146.04 and 200 EMA around Rs 1,118.59. This alignment indicates that the broader trend remains positive.
The 14-period daily RSI stands at 70.87, reflecting strong bullish momentum and entering the overbought zone. The positive EMA alignment, rising RSI and breakout above the previous resistance indicate strengthening buying pressure. Sustaining above the breakout level will be important for the continuation of the upward move.

The stock has now broken above the Rs 1,215–1,220 resistance zone with a strong bullish candle and closed at Rs 1,245.50, gaining 5.16%. Volume stood at approximately 3.66 million shares, indicating increased participation during the breakout. A sustained move above this resistance zone could confirm the completion of the rounding bottom formation and support further upside.

Trading Strategy and Key Levels

Considering the strong breakout from the rounding bottom formation, sustaining above the Rs 1,215–1,220 zone would keep the positive momentum intact. On the upside, the stock could move towards the Rs 1,300–1,330 range, followed by higher levels if the breakout sustains with continued buying interest.

Traders can keep a stop loss around Rs 1,170 to manage downside risk. A sustained hold above Rs 1,220 would strengthen the breakout structure, while a move back below the Rs 1,175 zone could weaken the setup.